AVMA news
NIH program in canine comparative oncology marks 20 years of progress
The National Institutes of Health created the Comparative Oncology Program two decades ago to advance the study of naturally occurring cancer in dogs,…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
AVMA news
In Short - Jan. 15, 2022
Cornell receives $30 million toward its Canine Health Center and a survey delves into veterinarians' understanding and practice of oncology around the…
AVMA news
Drug approved to treat dogs for chemotherapy-related diarrhea
Food and Drug Administration officials granted conditional approval in mid-December for the oral prescription drug Canalevia-CA1, the first drug with…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
AVMA news
AVMA honors four veterinary scientists
The Association hailed Drs. Yrjö Gröhn, Stephen White, Stanley Marks, and Mike Nolan for promoting animal and human health through their notable…
JAVMA news
Georgia alumni recognized for contributions
The University of Georgia College of Veterinary Medicine recently recognized five alumni for service to the college and the veterinary profession.
JAVMA news
AVMA Animal Health Studies Database reaches 5 years, 500 listings
This June, the AVMA Animal Health Studies Database is marking the fifth anniversary of its launch. The AAHSD also recently surpassed 500 listings of…